What does this research mean for the field?

Diabetes-related chronic inflammation disrupts the balance between myocardial damage and healing, leading to progressive left ventricular functional impairment in diabetic cardiomyopathy. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

May 1, 2022Minerva Cardiology and Angiology

Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damage

View Full Paper

Ask AI

Bookmark

Why the study?

Studies on diabetic cardiomyopathy clinical features and outcomes are few and conflicting, and the role of inflammation and potential anti-inflammatory strategies needed summarizing.

Design

Narrative review

Authors

EEEdoardo EliaAzienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo SMStefano MinistriniUniversity of Zurich FCFederico CarboneNorthwestern University

Discussion

Member takes

Implication

Does not support changing diabetic cardiomyopathy management; extends mechanistic understanding while leaving targeted therapies unproven.

Structured PICO

Population

Patients with diabetic cardiomyopathy

Intervention

Pharmacological strategies targeting inflammatory response

This review highlights the critical role of inflammation in the pathogenesis of diabetic cardiomyopathy and discusses potential targeted pharmacological strategies.

Cite This Study

Elia et al. (2022) studied this question.

synapsesocial.com/papers/6a1e899ac85b32e7cc55f684 https://doi.org/10.23736/s2724-5683.20.05454-7

View Full Paper

Ask AI

Bookmark

May 1, 2022Minerva Cardiology and Angiology

Diabetic cardiomyopathy and inflammation: development of hostile microenvironment resulting in cardiac damage

View Full Paper

Ask AI

Bookmark

Why the study?

Studies on diabetic cardiomyopathy clinical features and outcomes are few and conflicting, and the role of inflammation and potential anti-inflammatory strategies needed summarizing.

Design

Narrative review

Authors

EEEdoardo EliaAzienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo SMStefano MinistriniUniversity of Zurich FCFederico CarboneNorthwestern University

Discussion

Member takes

Implication

Does not support changing diabetic cardiomyopathy management; extends mechanistic understanding while leaving targeted therapies unproven.

Structured PICO

Population

Patients with diabetic cardiomyopathy

Intervention

Pharmacological strategies targeting inflammatory response

This review highlights the critical role of inflammation in the pathogenesis of diabetic cardiomyopathy and discusses potential targeted pharmacological strategies.

Cite This Study

Elia et al. (2022) studied this question.

synapsesocial.com/papers/6a1e899ac85b32e7cc55f684 https://doi.org/10.23736/s2724-5683.20.05454-7

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark